S. V. Taché, A. Sönnichsen, and D. M. Ashcroft, Prevalence of adverse drug events in ambulatory care: a systematic review, Ann Pharmacother, vol.45, issue.7-8, pp.977-89, 2011.

M. T. Martín, C. Codina, M. Tuset, X. Carné, S. Nogué et al.,

, Med Clin (Barc), vol.118, pp.205-215, 2002.

J. H. Gurwitz, T. S. Field, L. R. Harrold, J. Rothschild, K. Debellis et al., Incidence and preventability of adverse drug events among older persons in the ambulatory setting, JAMA, vol.289, issue.9, pp.1107-1123, 2003.

M. Pirmohamed, S. James, S. Meakin, C. Green, A. K. Scott et al., Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients, BMJ, vol.329, issue.7456, pp.15-24, 2004.

C. M. Hohl, J. Dankoff, A. Colacone, and M. Afilalo, Polypharmacy, adverse drug-related events, and potential adverse drug interactions in elderly patients presenting to an emergency department, Ann Emerg Med, vol.38, issue.6, pp.666-71, 2001.

T. Mayer, A. D. Meid, K. Saum, H. Brenner, B. Schöttker et al., Comparison of Nine Instruments to Calculate Anticholinergic Load in a Large Cohort of Older Outpatients: Association with Cognitive and Functional Decline, Falls, and Use of Laxatives, Am J Geriatr Psychiatry Off J Am Assoc Geriatr Psychiatry, vol.25, issue.5, pp.531-571, 2017.

S. L. Gray, M. L. Anderson, S. Dublin, J. T. Hanlon, R. Hubbard et al., Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study, JAMA Intern Med, vol.175, issue.3, pp.401-408, 2015.

H. Hamilton, P. Gallagher, C. Ryan, S. Byrne, O. 'mahony et al., Potentially inappropriate medications defined by STOPP criteria and the risk of adverse drug events in older hospitalized patients, Arch Intern Med, vol.171, issue.11, pp.1013-1022, 2011.

S. Legrain, Prescription to elderly patients: reducing underuse and adverse drug reactions and improving adherence

, Bull Acad Natl Med, vol.191, issue.2, pp.259-269, 2007.

, Projections de population pour la France métropolitaine à l'horizon 2050 -Insee Première -1089, 2018.

M. Kölzsch, K. Kopke, T. Fischer, W. Hofmann, R. Kuhnert et al., Prescribing of inappropriate medication in nursing home residents in Germany according to a French consensus list: a cross-sectional cohort study, Pharmacoepidemiol Drug Saf, 2011.

, gpn-295965-quelle_utilisation_les_medecins_generalistes_font_ils_des_tests_et_echelles_a_visee_geriatr ique_--W0Urv38AAQEAABvTQrIAAAAI-a.pdf, vol.20, pp.12-21, 2018.

. Agees and . Pdf, , 2018.

L. , , 2018.

A. Calderón-larrañaga, B. Poblador-plou, F. González-rubio, and L. A. Gimeno-feliu,

. Jm, A. Prados-torres, and . Multimorbidity, polypharmacy, referrals, and adverse drug events: are we doing things well?, Br J Gen Pract J R Coll Gen Pract, vol.62, issue.605, pp.821-826, 2012.

J. Lazarou, B. H. Pomeranz, and P. N. Corey, Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies, JAMA, vol.279, issue.15, pp.1200-1205, 1998.

J. W. Cooper, Adverse drug reaction-related hospitalizations of nursing facility patients: a 4-year study, South Med J, vol.92, issue.5, pp.485-90, 1999.

P. R. Obreli-neto, A. Nobili, A. De-oliveira-baldoni, C. M. Guidoni, and D. P. De-lyra-júnior,

D. , Adverse drug reactions caused by drug-drug interactions in elderly outpatients: a prospective cohort study, Eur J Clin Pharmacol, vol.68, issue.12, pp.1667-76, 2012.

S. Sourdet, C. Lafont, Y. Rolland, F. Nourhashemi, S. Andrieu et al.,

, Iatrogenic Disability in Elderly Patients During Hospitalization, J Am Med Dir Assoc, vol.16, issue.8, pp.674-81, 2015.

, Haute Autorité de Santé -Comment améliorer la qualité et la sécurité des prescriptions de médicaments chez la personne âgée ?, 2018.

P. Pilote, , 2006.

K. Ellett, L. M. Pratt, N. L. Ramsay, E. N. Barratt, J. D. Roughead et al., Multiple anticholinergic medication use and risk of hospital admission for confusion or dementia, J Am Geriatr Soc, vol.62, issue.10, pp.1916-1938, 2014.

M. S. Salahudeen, S. B. Duffull, and P. S. Nishtala, Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review, BMC Geriatr, vol.15, p.31, 2015.

G. Araklitis, G. Thiagamoorthy, J. Hunter, A. Rantell, D. Robinson et al.,

, Anticholinergic prescription: are healthcare professionals the real burden?, Int Urogynecology J, vol.28, issue.8, pp.1249-56, 2017.

L. Shamseer, D. Moher, M. Clarke, D. Ghersi, A. Liberati et al., Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation, BMJ, vol.350, p.7647, 201502.

M. H. Beers, J. G. Ouslander, I. Rollingher, D. B. Reuben, J. Brooks et al., Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine, Arch Intern Med, vol.151, issue.9, pp.1825-1857, 1991.

C. Chang, Y. Lai, H. Wu, R. Liu, H. Hsu et al., Using published criteria to develop a list of potentially inappropriate medications for elderly patients in Taiwan, Pharmacoepidemiol Drug Saf, vol.21, issue.12, pp.1269-79, 2012.

S. Kim, S. Jang, C. Kim, Y. Kim, and H. S. Sohn, Consensus Validated List of Potentially Inappropriate Medication for the Elderly and Their Prevalence in South Korea, Int J Gerontol

, Sep, vol.1, issue.3, pp.136-177

B. J. Basger, T. F. Chen, and R. J. Moles, Validation of prescribing appropriateness criteria for older Australians using the RAND/UCLA appropriateness method, BMJ Open, vol.2, issue.5, 2012.

M. Laroche, J. Charmes, and M. L. , Potentially inappropriate medications in the elderly: a French consensus panel list, Eur J Clin Pharmacol, vol.63, issue.8, pp.725-756, 2007.

S. Rognstad, M. Brekke, A. Fetveit, O. Spigset, T. B. Wyller et al., The Norwegian General Practice (NORGEP) criteria for assessing potentially inappropriate prescriptions to elderly patients. A modified Delphi study. Scand J Prim Health Care, vol.27, pp.153-162, 2009.

C. I. Lindblad, J. T. Hanlon, C. R. Gross, R. J. Sloane, C. F. Pieper et al., Clinically important drug-disease interactions and their prevalence in older adults, Clin Ther, 2006.

A. E. Stuck, M. H. Beers, A. Steiner, H. U. Aronow, L. Z. Rubenstein et al., Inappropriate medication use in community-residing older persons, Arch Intern Med, vol.154, pp.2195-200, 1994.

C. Zhan, J. Sangl, A. S. Bierman, M. R. Miller, B. Friedman et al., Potentially inappropriate medication use in the community-dwelling elderly: findings from the, 1996.

, Medical Expenditure Panel Survey. JAMA, vol.286, issue.22, pp.2823-2832, 2001.

D. M. Fick, J. W. Cooper, W. E. Wade, J. L. Waller, J. R. Maclean et al., Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts, Arch Intern Med, vol.163, issue.22, pp.2716-2740, 2003.

C. Rancourt, J. Moisan, L. Baillargeon, R. Verreault, D. Laurin et al., Potentially inappropriate prescriptions for older patients in long-term care, BMC Geriatr, vol.4, p.9, 2004.

M. Pugh, J. T. Hanlon, J. E. Zeber, A. Bierman, J. Cornell et al., Assessing potentially inappropriate prescribing in the elderly Veterans Affairs population using the HEDIS 2006 quality measure, J Manag Care Pharm JMCP, vol.12, issue.7, pp.537-582, 2006.

D. S. Kim, S. I. Heo, and S. H. Lee, Development of a list of potentially inappropriate drugs for the korean elderly using the delphi method, Healthc Inform Res, vol.16, issue.4, pp.231-52, 2010.

V. Maio, D. Canale, S. Abouzaid, and S. Investigators, Using explicit criteria to evaluate the quality of prescribing in elderly Italian outpatients: a cohort study, J Clin Pharm Ther, 2010.

, Apr, vol.35, issue.2, pp.219-248

A. Bachyrycz, M. A. Dodd, and G. Priloutskaya, Development and dissemination of a statewide system to minimize use of Potentially Inappropriate Medications (PIMs), 2012.

, By the American Geriatrics Society 2015 Beers Criteria Update Expert Panel, vol.50, pp.993-999

, Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults, Geriatrics Society, vol.63, issue.11, pp.2227-2273, 2015.

, American Geriatrics Society 2012 Beers Criteria Update Expert Panel

, Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults, J Am Geriatr Soc, vol.60, issue.4, pp.616-647, 2012.

M. H. Beers, Explicit criteria for determining potentially inappropriate medication use by the elderly. An update, Arch Intern Med, vol.157, issue.14, pp.1531-1537, 1997.

A. H. Lavan, P. Gallagher, C. Parsons, D. O'mahony, and . Stoppfrail, Screening Tool of Older Persons Prescriptions in Frail adults with limited life expectancy): consensus validation, Age Ageing, vol.46, issue.4, pp.600-607, 2017.

D. O'mahony, O. 'sullivan, D. Byrne, S. O'connor, M. N. Ryan et al., STOPP/START criteria for potentially inappropriate prescribing in older people: version 2, Age Ageing, vol.44, issue.2, pp.213-221, 2015.

D. Khodyakov, A. Ochoa, B. L. Olivieri-mui, C. Bouwmeester, B. J. Zarowitz et al.,

, Screening Tool of Older Person's Prescriptions/Screening Tools to Alert Doctors to Right Treatment Medication Criteria Modified for U.S. Nursing Home Setting, J Am Geriatr Soc, vol.65, issue.3, pp.586-91, 2017.

, PIM list: a list of potentially inappropriate medications for older people consented by experts from seven European countries, Eur J Clin Pharmacol, vol.71, issue.7, pp.861-75, 2015.

E. Tommelein, E. Mehuys, M. Petrovic, A. Somers, C. Van-damme et al.,

, Potentially inappropriate prescribing in nursing home residents detected with the community pharmacist specific GheOP(3)S-tool, Int J Clin Pharm, vol.38, issue.5, pp.1063-1071, 2016.

P. J. Mcleod, A. R. Huang, R. M. Tamblyn, and D. C. Gayton, Defining inappropriate practices in prescribing for elderly people: a national consensus panel, CMAJ Can Med Assoc J J Assoc Medicale Can, vol.156, issue.3, 1997.

P. Gallagher, C. Ryan, S. Byrne, J. Kennedy, D. O'mahony et al., Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment)

, Consensus validation, Int J Clin Pharmacol Ther, vol.46, issue.2, pp.72-83, 2008.

W. Winit-watjana, P. Sakulrat, and J. Kespichayawattana, Criteria for high-risk medication use in Thai older patients, Arch Gerontol Geriatr, vol.47, issue.1, pp.35-51, 2008.

S. Holt, S. Schmiedl, and P. A. Thürmann, Potentially inappropriate medications in the elderly: the PRISCUS list. Dtsch Arzteblatt Int, vol.107, pp.543-51, 2010.

E. Mann, B. Böhmdorfer, T. Frühwald, R. E. Roller-wirnsberger, P. Dovjak et al.,

C. Hofer, Potentially inappropriate medication in geriatric patients: the Austrian consensus panel list, Wien Klin Wochenschr, vol.124, issue.5-6, pp.160-169, 2012.

B. Clyne, M. C. Bradley, C. M. Hughes, D. Clear, R. Mcdonnell et al., Addressing potentially inappropriate prescribing in older patients: development and pilot study of an intervention in primary care (the OPTI-SCRIPT study), BMC Health Serv Res, vol.13, p.307, 2013.

A. M. Kuhn-thiel, C. Weiß, and M. Wehling, FORTA authors/expert panel members

, Consensus validation of the FORTA (Fit fOR The Aged) List: a clinical tool for increasing the appropriateness of pharmacotherapy in the elderly, Drugs Aging, vol.31, issue.2, pp.131-171, 2014.

A. O. Kanaan, J. L. Donovan, N. P. Duchin, T. S. Field, J. Tjia et al., Adverse drug events after hospital discharge in older adults: types, severity, and involvement of Beers Criteria Medications, J Am Geriatr Soc, vol.61, issue.11, pp.1894-1903, 2013.

G. Nyborg, J. Straand, A. Klovning, and M. Brekke, The Norwegian General Practice -Nursing Home criteria (NORGEP-NH) for potentially inappropriate medication use: A web-based Delphi study. Scand J Prim Health Care, vol.33, pp.134-175, 2015.

J. L. Rudolph, M. J. Salow, M. C. Angelini, and R. E. Mcglinchey, The anticholinergic risk scale and anticholinergic adverse effects in older persons, Arch Intern Med, vol.168, issue.5, pp.508-521, 2008.

R. M. Carnahan, B. C. Lund, P. J. Perry, B. G. Pollock, and K. R. Culp, The Anticholinergic Drug Scale as a measure of drug-related anticholinergic burden: associations with serum anticholinergic activity, J Clin Pharmacol, vol.46, issue.12, pp.1481-1487, 2006.

M. Boustani, N. Campbell, S. Munger, I. Maidment, and C. Fox, Impact of anticholinergics on the aging brain: a review and practical application. Aging Health, vol.4, pp.311-331, 2008.

L. Han, J. Mccusker, M. Cole, M. Abrahamowicz, F. Primeau et al., Use of medications with anticholinergic effect predicts clinical severity of delirium symptoms in older medical inpatients, Arch Intern Med, vol.161, issue.8, pp.1099-105, 2001.

M. L. Ancelin, S. Artero, F. Portet, A. Dupuy, J. Touchon et al., Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study, BMJ, vol.332, issue.7539, pp.455-464, 2006.
URL : https://hal.archives-ouvertes.fr/inserm-00000025

U. Ehrt, K. Broich, J. P. Larsen, C. Ballard, and D. Aarsland, Use of drugs with anticholinergic effect and impact on cognition in Parkinson's disease: a cohort study, J Neurol Neurosurg Psychiatry, vol.81, issue.2, pp.160-165, 2010.

S. N. Hilmer, D. E. Mager, E. M. Simonsick, Y. Cao, S. M. Ling et al., A drug burden index to define the functional burden of medications in older people, Arch Intern Med, vol.167, issue.8, pp.781-788, 2007.

G. Sittironnarit, D. Ames, A. I. Bush, N. Faux, L. Flicker et al., Effects of anticholinergic drugs on cognitive function in older Australians: results from the AIBL study

, Dement Geriatr Cogn Disord, vol.31, issue.3, pp.173-181, 2011.

P. Lampela, A. Tolppanen, A. Tanskanen, J. Tiihonen, S. Hartikainen et al.,

, Anticholinergic Exposure and Risk of Pneumonia in Persons with Alzheimer's Disease: A Nested Case-Control Study, J Alzheimers Dis JAD, vol.56, issue.1, pp.119-147, 2017.

S. Chatterjee, R. M. Carnahan, H. Chen, H. M. Holmes, M. L. Johnson et al.,

, Anticholinergic Medication Use and Risk of Pneumonia in Elderly Adults: A Nested Case-Control Study, J Am Geriatr Soc, vol.64, issue.2, pp.394-400, 2016.

C. V. Bostock, R. L. Soiza, and A. A. Mangoni, Associations between different measures of anticholinergic drug exposure and Barthel Index in older hospitalized patients, Ther Adv Drug Saf, vol.4, issue.6, pp.235-280, 2013.

A. Kolanowski, J. Mogle, D. M. Fick, N. Campbell, N. Hill et al., Anticholinergic Exposure During Rehabilitation: Cognitive and Physical Function Outcomes in Patients with Delirium Superimposed on Dementia, Am J Geriatr Psychiatry Off J Am Assoc Geriatr Psychiatry, vol.23, issue.12, pp.1250-1258, 2015.

G. Lucchetti and A. Lucchetti, Inappropriate prescribing in older persons: A systematic review of medications available in different criteria, Arch Gerontol Geriatr, vol.68, pp.55-61, 2017.

F. R. Motter, J. S. Fritzen, S. N. Hilmer, É. V. Paniz, and V. Paniz, Potentially inappropriate medication in the elderly: a systematic review of validated explicit criteria, Eur J Clin Pharmacol, 2018.

M. M. Islam, U. Iqbal, B. Walther, S. Atique, N. K. Dubey et al., Benzodiazepine Use and Risk of Dementia in the Elderly Population: A Systematic Review and Meta-Analysis

, Neuroepidemiology, vol.47, issue.3-4, pp.181-91, 2016.

N. T. Vozoris, H. D. Fischer, X. Wang, G. M. Anderson, C. M. Bell et al.,

, Benzodiazepine use among older adults with chronic obstructive pulmonary disease: a population-based cohort study. Drugs Aging, vol.30, pp.183-92, 2013.

R. M. Leipzig, R. G. Cumming, and M. E. Tinetti, Drugs and falls in older people: a systematic review and meta-analysis: II. Cardiac and analgesic drugs, J Am Geriatr Soc, 1999.

C. Tannenbaum, P. Martin, R. Tamblyn, A. Benedetti, and S. Ahmed, Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: the EMPOWER cluster randomized trial, JAMA Intern Med, vol.174, issue.6, pp.890-898, 2014.

L. E. Hines and J. E. Murphy, Potentially harmful drug-drug interactions in the elderly: a review, Am J Geriatr Pharmacother, vol.9, issue.6, pp.364-77, 2011.

P. Magin, S. Goode, and D. Pond, GPs, medications and older people: A qualitative study of general practitioners' approaches to potentially inappropriate medications in older people

, Australas J Ageing, vol.34, issue.2, pp.134-143, 2015.

C. E. Durán, M. Azermai, and R. H. Vander-stichele, Systematic review of anticholinergic risk scales in older adults, Eur J Clin Pharmacol, vol.69, issue.7, pp.1485-96, 2013.

S. M. Ozalas, V. Huang, L. Brunetti, and T. Reilly, Comparison of Two Versions of the Beers Criteria and Adverse Outcomes in Older Hospitalized Patients, Consult Pharm J Am Soc Consult Pharm, vol.32, issue.12, pp.752-63, 2017.

K. J. Nauta, F. Groenhof, J. Schuling, J. G. Hugtenburg, H. Van-hout et al., Application of the STOPP/START criteria to a medical record database

, Pharmacoepidemiol Drug Saf, vol.26, issue.10, pp.1242-1249, 2017.

O. Dalleur, J. Feron, and A. Spinewine, Views of general practitioners on the use of STOPP&START in primary care: a qualitative study, Acta Clin Belg, vol.69, issue.4, pp.251-61, 2014.

, /2): Critères STOPP/START version 2 ANNEXE 12 : Critèes STOPP/START for nursing home 80, ANNEXE, vol.11, issue.1